116 STAT. 694 PUBLIC LAW 107-188-JUNE 12, 2002 21 USC 379g SEC. 507. SAVINGS CLAUSE. Notwithstanding section 107 of the Food and Drug Administration Modernization Act of 1997, and notwithstanding the amendments made by this subtitle, part 2 of subchapter C of chapter VII of the Federal Food, Drug, and Cosmetic Act, as in effect on the day before the date of the enactment of this Act, continues to be in effect with respect to human drug applications and supplements (as defined in such part as of such day) that, on or after October 1, 1997, but before October 1, 2002, were accepted by the Food and Drug Administration for filing and with respect to assessing and collecting any fee required by such Act for a fiscal year prior to fiscal year 2003. 21 USC 356b SEC. 508. EFFECTIVE DATE. The amendments made by this subtitle shall take effect October 1, 2002. 21 USC 379g SEC. 509. SUNSET CLAUSE. The amendments made by sections 503 and 504 cease to be effective October 1, 2007, and section 505 ceases to be effective 120 days after such date. Subtitle B—Funding Provisions Regarding Food and Drug Administration SEC. 521. OFFICE OF DRUG SAFETY. Of the amounts appropriated for the Food and Drug Administration for a fiscal year, the Secretary of Health and Human Services shall reserve for the Office of Drug Safety (within such Administration), the following amounts: (1) For fiscal year 2003, an amount equal to the sum of $5,000,000 and the amount made available under appropriations Acts for such Office for fiscal year 2002. (2) For fiscal year 2004, an amount equal to the sum of $10,000,000 and the amount made available under appropriations Acts for such Office for fiscal year 2002. (3) For each subsequent fiscal year, an amount equal to the sum of the amount made available under appropriations Acts for such Office for fiscal year 2004 and an amount sufficient to offset the effects of inflation occurring after the beginning of fiscal year 2004. Appropriation SEC. 522. DIVISION OF DRUG MARKETING, ADVERTISING, AND COMMU- authorization. NTCATIONS. For the Division of Drug Marketing, Advertising, and Communications (within the Office of Medical Policy, Food and Drug Administration), there are authorized to be appropriated the following amounts, stated as increases above the amount made available under appropriations Acts for such Division for fiscal year 2002: (1) For fiscal year 2003, an increase of $2,500,000. (2) For fiscal year 2004, an increase of $4,000,000. (3) For fiscal year 2005, an increase of $5,500,000. (4) For fiscal year 2006, an increase of $7,500,000. (5) For fiscal year 2007, an increase of $7,500,000.
�
